Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/6666

TDMS Study 60968-02 Pathology Tables

NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05

                                                           CORE STUDY




       Facility:  Battelle Northwest

       Chemical CAS #:  0078-84-2

       Lock Date:  05/12/94

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1

NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      500 PPM      1000 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                16           13           11           11                                     
    Natural Death                                      5            4            3            2                                     
    Accidently Killed                                  1            1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                28           32           35           37                                     
    Natural Death                                                                1                                                  
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (46)         (44)         (45)         (47)                                   
      Hyperplasia                                                   1 (2%)                    1 (2%)                                
   Intestine Small, Ileum                             (49)         (46)         (47)         (49)                                   
      Hyperplasia, Lymphoid                            1 (2%)                    1 (2%)                                             
   Liver                                              (49)         (49)         (50)         (50)                                   
      Angiectasis                                                                2 (4%)                                             
      Basophilic Focus                                 1 (2%)       3 (6%)       2 (4%)       3 (6%)                                
      Clear Cell Focus                                 1 (2%)                    2 (4%)                                             
      Cyst                                                          1 (2%)       1 (2%)                                             
      Eosinophilic Focus                               6 (12%)      7 (14%)      5 (10%)      4 (8%)                                
      Hematopoietic Cell Proliferation                              1 (2%)                    1 (2%)                                
      Mixed Cell Focus                                                           1 (2%)                                             
      Necrosis                                         4 (8%)       3 (6%)       1 (2%)       1 (2%)                                
      Tension Lipidosis                                3 (6%)                    2 (4%)                                             
      Thrombosis                                                    1 (2%)                                                          
      Centrilobular, Necrosis                          1 (2%)       2 (4%)       2 (4%)                                             
   Mesentery                                          (8)          (2)          (4)          (3)                                    
      Hemorrhage                                                                              1 (33%)                               
      Fat, Necrosis                                    6 (75%)      2 (100%)                  2 (67%)                               
   Pancreas                                           (50)         (49)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                 1 (2%)                                
      Basophilic Focus                                 1 (2%)                                                                       
      Cyst                                             2 (4%)       1 (2%)                    1 (2%)                                
      Hypertrophy                                                                1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)       2 (4%)                                
      Lipomatosis                                      4 (8%)       1 (2%)       3 (6%)       3 (6%)                                
      Thrombosis                                       1 (2%)                                                                       
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Diverticulum                                                                            1 (2%)                                
      Hyperplasia, Squamous                            1 (2%)       1 (2%)                    3 (6%)                                
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       1 (2%)       3 (6%)                                
   Stomach, Glandular                                 (49)         (49)         (50)         (50)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      500 PPM      1000 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic Active                                               1 (2%)                                             
      Mineralization                                                1 (2%)                                                          
   Tooth                                                                                     (1)                                    
      Developmental Malformation                                                              1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                   9 (18%)     12 (24%)     10 (20%)      7 (14%)                               
      Artery, Mineralization                                        1 (2%)                                                          
      Atrium, Thrombosis                               1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (49)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                                                       
      Degeneration, Fatty                              2 (4%)       2 (4%)       1 (2%)       1 (2%)                                
      Hyperplasia                                      5 (10%)      3 (6%)                    1 (2%)                                
      Hypertrophy                                                                1 (2%)       1 (2%)                                
      Necrosis                                                                   1 (2%)                                             
   Adrenal Medulla                                    (50)         (49)         (50)         (50)                                   
      Hyperplasia                                      5 (10%)      3 (6%)       2 (4%)       1 (2%)                                
   Pituitary Gland                                    (50)         (49)         (50)         (49)                                   
      Pars Distalis, Hyperplasia                      19 (38%)     23 (47%)     23 (46%)     17 (35%)                               
      Pars Intermedia, Hyperplasia                                               1 (2%)                                             
      Pars Intermedia, Hypertrophy                     1 (2%)                                 1 (2%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Follicular Cell, Hyperplasia                    18 (36%)     26 (52%)     24 (48%)     32 (64%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (44)         (39)         (40)         (40)                                   
      Inflammation, Chronic Active                                  1 (3%)                                                          
   Ovary                                              (50)         (49)         (50)         (50)                                   
      Angiectasis                                                                2 (4%)                                             
      Cyst                                            13 (26%)     15 (31%)     14 (28%)     18 (36%)                               
      Hyperplasia                                                                             1 (2%)                                
      Interstitial Cell, Hyperplasia                                                          1 (2%)                                
   Uterus                                             (50)         (50)         (50)         (50)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      500 PPM      1000 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Angiectasis                                      2 (4%)                                 1 (2%)                                
      Hemorrhage                                                                 1 (2%)                                             
      Hydrometra                                       4 (8%)       4 (8%)       6 (12%)      7 (14%)                               
      Inflammation, Suppurative                                     1 (2%)                                                          
      Thrombosis                                                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (5)          (5)          (4)          (4)                                    
      Lumbar, Ectasia                                                            1 (25%)                                            
      Lumbar, Hemorrhage                                                                      1 (25%)                               
   Lymph Node, Bronchial                              (42)         (38)         (42)         (44)                                   
      Hemorrhage                                       1 (2%)                                                                       
   Lymph Node, Mesenteric                             (48)         (49)         (47)         (47)                                   
      Angiectasis                                                                             1 (2%)                                
      Necrosis                                                                   1 (2%)                                             
   Spleen                                             (50)         (49)         (50)         (50)                                   
      Congestion                                       1 (2%)                                                                       
      Hematopoietic Cell Proliferation                11 (22%)     11 (22%)     11 (22%)      9 (18%)                               
      Hyperplasia, Lymphoid                            2 (4%)       2 (4%)       3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic Active                                                            1 (2%)                                
      Subcutaneous Tissue, Angiectasis                                           1 (2%)                                             
      Subcutaneous Tissue, Necrosis                                                           1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fracture                                                      1 (2%)                                                          
      Hyperostosis                                                               1 (2%)                                             
   Skeletal Muscle                                                 (1)          (1)                                                 
      Hemorrhage                                                    1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Meninges, Infiltration Cellular, Mononuclear                                                                                  
          Cell                                                                                1 (2%)                                
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      500 PPM      1000 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (50)         (50)         (49)         (50)                                   
      Inflammation, Suppurative                                                  1 (2%)                                             
      Epiglottis, Hyperplasia                                                                 1 (2%)                                
      Epiglottis, Metaplasia, Squamous                                                        1 (2%)                                
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion, Chronic                              1 (2%)                                                                       
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Inflammation, Suppurative                        1 (2%)                                                                       
      Mineralization                                                                          1 (2%)                                
      Thrombosis                                                    1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia                 3 (6%)       3 (6%)                    1 (2%)                                
      Alveolus, Infiltration Cellular, Histiocyte      2 (4%)       2 (4%)       1 (2%)                                             
      Bronchiole, Hyperplasia                          1 (2%)                                                                       
      Interstitium, Fibrosis                           1 (2%)                                                                       
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                        1 (2%)       1 (2%)       1 (2%)                                             
      Thrombosis                                                    1 (2%)                                                          
      Olfactory Epithelium, Degeneration               1 (2%)       1 (2%)      27 (54%)     49 (98%)                               
      Olfactory Epithelium, Degeneration, Hyaline                                1 (2%)                                             
      Olfactory Epithelium, Necrosis                                             2 (4%)       1 (2%)                                
      Respiratory Epithelium, Necrosis                                           1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                                                       (3)                                    
      Cornea, Mineralization                                                                  2 (67%)                               
      Lens, Mineralization                                                                    1 (33%)                               
   Harderian Gland                                    (3)          (4)          (2)          (2)                                    
      Hyperplasia                                                                             1 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Amyloid Deposition                               2 (4%)       1 (2%)                                                          
      Atrophy                                                                    1 (2%)                                             
      Cyst                                             1 (2%)                    1 (2%)                                             
      Infarct                                          1 (2%)       2 (4%)                    2 (4%)                                
      Metaplasia, Osseous                                           1 (2%)       4 (8%)       1 (2%)                                
      Mineralization                                                1 (2%)       2 (4%)                                             
      Nephropathy                                     23 (46%)     20 (40%)     15 (30%)     20 (40%)                               
      Pelvis, Dilatation                                                         1 (2%)                                             
      Pelvis, Inflammation, Acute                      1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      500 PPM      1000 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Renal Tubule, Necrosis                                        1 (2%)       1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      500 PPM      1000 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 6            8            6           15                                     
    Natural Death                                      4            5            9            5                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                40           37           35           30                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (47)         (43)         (42)         (44)                                   
      Hyperplasia                                      1 (2%)       2 (5%)       2 (5%)                                             
   Intestine Large, Cecum                             (49)         (48)         (48)         (48)                                   
      Fibrosis                                                      1 (2%)                                                          
      Parasite Metazoan                                                          1 (2%)                                             
   Liver                                              (49)         (50)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Basophilic Focus                                 4 (8%)       8 (16%)      3 (6%)       4 (8%)                                
      Clear Cell Focus                                 2 (4%)       7 (14%)      3 (6%)       2 (4%)                                
      Cyst                                                                                    1 (2%)                                
      Degeneration, Fatty                                                        1 (2%)                                             
      Eosinophilic Focus                               3 (6%)       6 (12%)      3 (6%)       3 (6%)                                
      Infarct, Focal                                   1 (2%)                    2 (4%)                                             
      Mixed Cell Focus                                              2 (4%)                    1 (2%)                                
      Necrosis                                         1 (2%)       1 (2%)       1 (2%)       2 (4%)                                
      Tension Lipidosis                                                          1 (2%)                                             
      Centrilobular, Necrosis                                       1 (2%)       1 (2%)                                             
   Mesentery                                          (1)          (3)          (5)          (3)                                    
      Artery, Inflammation                                          1 (33%)                                                         
      Fat, Necrosis                                    1 (100%)     2 (67%)      4 (80%)      2 (67%)                               
   Pancreas                                           (50)         (49)         (50)         (50)                                   
      Atrophy                                          1 (2%)                    1 (2%)                                             
      Cyst                                                                                    1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                                 1 (2%)                                
      Lipomatosis                                      2 (4%)       2 (4%)       2 (4%)       5 (10%)                               
      Necrosis                                         1 (2%)                                                                       
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Diverticulum                                     1 (2%)                                                                       
      Inflammation, Chronic Active                     2 (4%)       2 (4%)       2 (4%)       1 (2%)                                
   Stomach, Glandular                                 (50)         (50)         (49)         (50)                                   
      Inflammation, Chronic Active                                  1 (2%)       2 (4%)       1 (2%)                                
      Artery, Inflammation                                                       1 (2%)                                             
   Tooth                                                           (3)          (2)                                                 
      Developmental Malformation                                    3 (100%)     1 (50%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      500 PPM      1000 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  26 (52%)     30 (60%)     26 (52%)     27 (54%)                               
      Inflammation, Suppurative                                                               1 (2%)                                
      Mineralization                                                             1 (2%)                                             
      Atrium, Thrombosis                                                         1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                                                       
      Hyperplasia                                     14 (28%)     21 (42%)     18 (36%)     18 (36%)                               
      Hypertrophy                                     32 (64%)     21 (42%)     26 (52%)     26 (52%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
   Pituitary Gland                                    (49)         (47)         (49)         (49)                                   
      Cyst                                                                       1 (2%)                                             
      Pars Distalis, Hyperplasia                       3 (6%)       3 (6%)                                                          
      Pars Intermedia, Hyperplasia                                               1 (2%)       1 (2%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Follicular Cell, Hyperplasia                    11 (22%)     11 (22%)     14 (28%)     12 (24%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Granuloma Sperm                                  1 (2%)                                                                       
   Penis                                                                        (1)          (2)                                    
      Inflammation, Chronic Active                                                            1 (50%)                               
   Preputial Gland                                    (50)         (50)         (49)         (50)                                   
      Cyst                                             7 (14%)      9 (18%)      6 (12%)      4 (8%)                                
      Inflammation, Chronic Active                     1 (2%)       2 (4%)       3 (6%)       5 (10%)                               
   Prostate                                           (49)         (50)         (47)         (48)                                   
      Hyperplasia                                                                1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       2 (4%)                                             
   Seminal Vesicle                                    (50)         (50)         (50)         (50)                                   
      Inflammation, Acute                              1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                     2 (4%)       1 (2%)                                                          
   Testes                                             (50)         (50)         (50)         (50)                                   
      Degeneration                                     1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      500 PPM      1000 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                                                                (4)                                    
      Iliac, Infiltration Cellular, Plasma Cell                                               1 (25%)                               
   Lymph Node, Mesenteric                             (50)         (48)         (47)         (47)                                   
      Angiectasis                                                                             1 (2%)                                
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Angiectasis                                                                1 (2%)                                             
      Hematopoietic Cell Proliferation                 7 (14%)      7 (14%)      8 (16%)      9 (18%)                               
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                    1 (2%)                                
   Thymus                                             (39)         (39)         (42)         (36)                                   
      Artery, Inflammation                                                       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)       2 (4%)       2 (4%)                                             
      Necrosis                                                      1 (2%)                                                          
      Prepuce, Inflammation, Acute                     3 (6%)       4 (8%)       4 (8%)       9 (18%)                               
      Subcutaneous Tissue, Edema                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                                               1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (50)         (49)         (50)         (50)                                   
      Inflammation, Suppurative                                     1 (2%)                                                          
      Epiglottis, Hyperplasia                          1 (2%)                    1 (2%)                                             
      Epiglottis, Metaplasia, Squamous                 1 (2%)       1 (2%)       1 (2%)       3 (6%)                                
      Glands, Inflammation, Suppurative                             1 (2%)       1 (2%)       3 (6%)                                
   Lung                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                                     1 (2%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Pigmentation                                     1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                 3 (6%)       3 (6%)       3 (6%)       2 (4%)                                
      Alveolus, Infiltration Cellular, Histiocyte                                1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 60968-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          ISOBUTYRALDEHYDE                                     Date: 09/23/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:07:05  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      500 PPM      1000 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Artery, Mediastinum, Mineralization              1 (2%)       1 (2%)                                                          
      Bronchiole, Hyperplasia                          2 (4%)                                                                       
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                                     2 (4%)       1 (2%)       3 (6%)                                
      Nasolacrimal Duct, Hyperplasia                   1 (2%)                                                                       
      Nasolacrimal Duct, Inflammation, Suppurative     1 (2%)                                                                       
      Olfactory Epithelium, Degeneration                                        11 (22%)     45 (90%)                               
      Olfactory Epithelium, Necrosis                                                          1 (2%)                                
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                                     1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                                          (1)                                                 
      Cornea, Inflammation, Chronic Active                                       1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                             3 (6%)       3 (6%)       1 (2%)       1 (2%)                                
      Infarct                                          2 (4%)       1 (2%)       1 (2%)       5 (10%)                               
      Mineralization                                   1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Necrosis                                                                                1 (2%)                                
      Nephropathy                                     45 (90%)     46 (92%)     44 (88%)     45 (90%)                               
      Artery, Inflammation                                                                    2 (4%)                                
      Pelvis, Dilatation                                                         1 (2%)                                             
      Pelvis, Inflammation, Acute                      2 (4%)       1 (2%)       2 (4%)       2 (4%)                                
      Transitional Epithelium, Hyperplasia                                       1 (2%)                                             
   Urinary Bladder                                    (50)         (50)         (48)         (50)                                   
      Inflammation, Acute                                                                     1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                    2 (4%)       3 (6%)                                
      Mineralization                                   1 (2%)                                                                       
      Artery, Inflammation                                                       1 (2%)                                             
      Transitional Epithelium, Hyperplasia             1 (2%)                                 1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------